Niaid

HIV vaccine effectiveness study launched in South Africa, first in seven years

The first HIV vaccine efficacy study in seven years has begun in South Africa to test whether a modified vaccine candidate can provide effective protection against the AIDS virus, the US National Institutes of Health said.

HIV vaccine efficiacy study begins in South Africa, results expected in 2020

Volunteers will been randomly assigned to receive either the investigational vaccine regimen or a placebo.